TriMas (TRS) Expected to Announce Quarterly Earnings on Thursday

TriMas (NASDAQ:TRS) is expected to be releasing its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect TriMas to post earnings of $0.41 per share and revenue of $192.9560 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:00 AM ET.

TriMas Trading Up 1.2%

NASDAQ:TRS opened at $37.03 on Thursday. TriMas has a 52 week low of $19.33 and a 52 week high of $40.34. The firm has a 50-day moving average price of $35.18 and a two-hundred day moving average price of $35.90. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.42 and a current ratio of 2.68. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of 34.29 and a beta of 0.57.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of TRS. Man Group plc bought a new stake in TriMas during the 4th quarter worth approximately $206,000. Simplex Trading LLC increased its holdings in shares of TriMas by 264.7% in the fourth quarter. Simplex Trading LLC now owns 9,846 shares of the industrial products company’s stock worth $349,000 after purchasing an additional 7,146 shares during the period. PharVision Advisers LLC purchased a new stake in shares of TriMas in the third quarter worth $207,000. Moneta Group Investment Advisors LLC purchased a new stake in shares of TriMas in the 3rd quarter valued at about $204,000. Finally, Captrust Financial Advisors bought a new stake in shares of TriMas during the 2nd quarter valued at about $355,000. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TRS. KeyCorp cut their price target on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Zacks Research lowered shares of TriMas from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 11th. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research report on Monday, December 29th. BWS Financial restated a “buy” rating and set a $45.00 price target on shares of TriMas in a research note on Friday, December 5th. Finally, Wall Street Zen cut shares of TriMas from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, TriMas has an average rating of “Moderate Buy” and an average target price of $41.50.

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.